Document is current
Any future updates will be listed below
-
Authors
Abou-Shanab, Ahmed M.
Shouman, Shaimaa
Hussein, Alaa E.
Gaser, Ola A.
Magdy, Shireen
Ashraf, Eman
Salah, Radwa Ayman
Idris, Omaima
El-Badri, Nagwa
-
Funding
Funding for this research was provided by:
Science, Technology & Innovation Funding Authority (STDF): FLUG grant (46721, 46721, 46721, 46721, 46721, 46721)
ASRT: Bedayti graduation project grant (2023, 2023, 2023)
Egyptian Academy of Scientific Research and Technology (ASRT): JESOR grant (5275, 5275, 5275, 5275)
Zewail City of Science & Technology
- License Information
-
More Information
Article History
Received: 20 October 2024
Accepted: 4 June 2025
First Online: 19 June 2025
Declarations
:
: Human amniotic membrane (hAM) was ethically sourced to ensure patient safety and regulatory compliance. We obtained hAM following elective cesarean sections from healthy subjects who underwent thorough screening and testing negative for blood-borne infections. Prior to tissue collection, written informed consent was obtained from all participating subjects. All study procedures, including patient recruitment, consent acquisition, and hAM processing, were reviewed and approved by the Institutional Review Board (IRB) at Sheikh Zayed Specialized Hospital. We adhered to all relevant ethical guidelines and regulations throughout the study to ensure the well-being of the mothers and the integrity of the research.
: Not applicable.
: The authors declare no competing interests.
